Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Hackensack Meridian Health
Hackensack Meridian Health
National Cancer Institute (NCI)
Medical College of Wisconsin
National Cancer Institute (NCI)
Janssen Research & Development, LLC
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
University of Illinois at Chicago
National Heart, Lung, and Blood Institute (NHLBI)
University of Nebraska
City of Hope Medical Center
Washington University School of Medicine
Duke University
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northside Hospital, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
H. Lee Moffitt Cancer Center and Research Institute
Ludwig Institute for Cancer Research
Hackensack Meridian Health
Memorial Sloan Kettering Cancer Center
University of Iowa
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
University of Arkansas
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Mayo Clinic
Albert Einstein College of Medicine
University of California, San Francisco
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Columbia University
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Acrotech Biopharma Inc.
Washington University School of Medicine
Celgene
Roswell Park Cancer Institute
University of Illinois at Chicago